Literature DB >> 20802996

Gout and coexisting pseudogout in the knee joint.

Yonsik Yoo1, Young-Jin Seo, Mina Huh, Je Hyun Yoo, Kyu Ho Yun, Sung-Jae Kim.   

Abstract

PURPOSE: We report the unusual case of a 63-year-old man with gout and coexisting pseudogout (calcium pyrophosphate dihydrate crystal deposition disease) affecting the same joint. In this report, we describe the clinical features of the patient in addition to the characteristics of the crystals extracted from his affected joint, examined using compensated polarized microscopy.
METHODS: Synovial fluid and specimens of the lateral meniscus of the patient's knee joint taken during arthroscopy were analyzed using compensated polarized microscopy to evaluate the presence and type of crystals.
RESULTS: Compensated polarized microscopy revealed both monosodium urate (MSU) and calcium pyrophosphate dihydrate (CPPD) crystals extracted from the knee joint.
CONCLUSIONS: Our findings suggest that the coexistence of gout and pseudogout should be considered in the diagnosis of crystal-induced arthritis. Careful crystal evaluation using compensated polarized microscopy may reveal similar cases with MSU and CPPD crystals in the same joint.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20802996     DOI: 10.1007/s00167-010-1236-8

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  12 in total

1.  Tophaceous gout and pseudogout of the middle ear and the infratemporal fossa: case report and review of the literature.

Authors:  Issam Saliba; Alain Bouthiller; Pascal Desrochers; France Berthlet; Jean-Jacques Dufour
Journal:  J Otolaryngol       Date:  2003-08

2.  The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals.

Authors:  N N KOHN; R E HUGHES; D J McCARTY; J S FAIRES
Journal:  Ann Intern Med       Date:  1962-05       Impact factor: 25.391

3.  Gout and pseudogout of the temporomandibular joint.

Authors:  B D Gross; R B Williams; C J DiCosimo; S V Williams
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1987-05

4.  The prevalence of chondrocalcinosis in the elderly and its association with knee osteoarthritis: the Framingham Study.

Authors:  D T Felson; J J Anderson; A Naimark; W Kannel; R F Meenan
Journal:  J Rheumatol       Date:  1989-09       Impact factor: 4.666

Review 5.  Crystal identification in human synovial fluids. Methods and interpretation.

Authors:  D J McCarty
Journal:  Rheum Dis Clin North Am       Date:  1988-08       Impact factor: 2.670

6.  Chondrocalcinosis in elderly persons.

Authors:  M H Ellman; B Levin
Journal:  Arthritis Rheum       Date:  1975 Jan-Feb

7.  Frequency of chondrocalcinosis of the knees and avascular necrosis of the femoral heads in gout: a controlled study.

Authors:  A Stockman; L G Darlington; J T Scott
Journal:  Ann Rheum Dis       Date:  1980-02       Impact factor: 19.103

Review 8.  Crystal arthritis. Gout and pseudogout in the geriatric patient.

Authors:  Michael Cassetta; Peter D Gorevic
Journal:  Geriatrics       Date:  2004-09

Review 9.  Diseases associated with calcium pyrophosphate deposition disease.

Authors:  A C Jones; A J Chuck; E A Arie; D J Green; M Doherty
Journal:  Semin Arthritis Rheum       Date:  1992-12       Impact factor: 5.532

10.  Coexisting psoriatic arthritis, gout, and chondrocalcinosis.

Authors:  C De Bari; G Lapadula; F P Cantatore
Journal:  Scand J Rheumatol       Date:  1998       Impact factor: 3.641

View more
  2 in total

1.  Pseudogout - a rare manifestation of hungry bone syndrome after focused parathyroidectomy.

Authors:  C H Tai; H B Oh; J E Seet; K Y Ngiam
Journal:  Ann R Coll Surg Engl       Date:  2018-04-01       Impact factor: 1.891

2.  Ultrasonography, an operator-dependent modality versus dual-energy computed tomography (DECT) in the detection of chondrocalcinosis: with regard to Tanikawa et al.'s study.

Authors:  Angel Checa
Journal:  J Orthop Surg Res       Date:  2018-10-16       Impact factor: 2.359

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.